NCT05089006

Brief Summary

This study aim to analyze cost-effectiveness of robot-assisted surgery compared to open surgery for partial nephrectomy in the context of renal tumor. A total of 400 patients were recruited in two centers in France corresponding to Reims(n=200) and Nancy hospital center (n=200). Patients recruited in Reims are corresponding to open surgery strategy, while patients of Nancy center are corresponding to robot-assisted surgery. Costs analyzed included cost of intervention, hospital stay and complications. Effectiveness measure is corresponding to the rate of patients without acute complication at one year.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2008

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
11 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 22, 2021

Completed
Last Updated

October 22, 2021

Status Verified

October 1, 2021

Enrollment Period

11 years

First QC Date

October 8, 2021

Last Update Submit

October 21, 2021

Conditions

Keywords

kidney cancerrobot-assisted surgerycost-effectiveness

Outcome Measures

Primary Outcomes (1)

  • Incremental cost-effectiveness ratio estimating cost per one acute post-operative complication averted

    post-operative complication represents a relevant indicator in the context of renal nephrectomy. We aim to estimate the cost associated with one complication averted

    one year

Secondary Outcomes (1)

  • Difference in hospital stay duration between robot-assisted and open surgery

    one year

Study Arms (2)

robot-assisted surgery group

Patients undergoing robot-assisted surgery for small renal tumor

Procedure: Partial nephrectomy with robot-assisted and open surgery

open surgery group

Patients undergoing open surgery for small renal tumor

Procedure: Partial nephrectomy with robot-assisted and open surgery

Interventions

Robot-assisted partial nephrectomy (RAPN) is considered as a feasible minimally invasive alternative to open partial nephrectomy (OPN) for the surgical treatment of renal tumors. The main advantages of this technique include a three-dimensional magnified view of the surgical field, enhanced dexterity, and greater precision in both dissection and reconstruction.

open surgery grouprobot-assisted surgery group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients over 18 years old that undergone partial nephrectomy in Nancy and Reims center for small renal tumor.

You may qualify if:

  • Patients undergoing partial nephrectomy surgery for renal tumor
  • Patients that gave informed consent for participating to the study

You may not qualify if:

  • Patients undergoing partial nephrectomy surgery for other indication
  • Patients that refused participation to the study
  • Patients with horseshoe kidney
  • Patients undergoing total nephrectomy for renal tumor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Baghli A, Achit H, Audige V, Larre S, Branchu B, Balkau B, Eschwege P, Hubert J, Mazeaud C. Cost-effectiveness of robotic-assisted surgery vs open surgery in the context of partial nephrectomy for small kidney tumors. J Robot Surg. 2023 Aug;17(4):1571-1578. doi: 10.1007/s11701-023-01552-8. Epub 2023 Mar 15.

MeSH Terms

Conditions

Carcinoma, Renal CellKidney Neoplasms

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professeur

Study Record Dates

First Submitted

October 8, 2021

First Posted

October 22, 2021

Study Start

January 1, 2008

Primary Completion

January 1, 2019

Study Completion

June 1, 2021

Last Updated

October 22, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

no personal data will be shared